We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Novel Non-Invasive Sampling Technique Diagnoses Cutaneous Leishmaniasis

By LabMedica International staff writers
Posted on 27 Jul 2017
The definitive diagnosis of cutaneous leishmaniasis requires parasitological detection and it is usually based on direct detection of amastigotes in smears from lesions by microscopy and by the culturing of promastigotes from infected tissues.

Although these techniques are highly specific, they require highly skilled health workers and have the inherent risks of all invasive procedures, such as pain and risk of bacterial and fungal super-infection. More...
Therefore, it is essential to reduce discomfort, potential infection and scarring caused by invasive diagnostic approaches especially for children.

Scientists at the Pasteur Institute of Iran (Tehran, Iran) working with their colleagues at the Imperial College London (London, UK) recruited 119 patients suspected of suffering from cutaneous leishmaniasis with different clinical manifestations and samples were collected both from their lesions and from uninfected areas. In addition, 15 fungal-infected lesions and 54 areas of healthy skin were examined. There were 49 female and 70 males and the median age was 30 years (average 33 ± 20.3, range: 1 to 79 years old). The touch smear of dermal tissue of each patient was prepared by superficial incision on the margin of the lesion against a glass microscope slide, stained and examined.

For non-invasive skin sampling, one tape disc was placed on selected areas (infected and non-infected areas). In order to apply even pressure to the disc, a plunger was gently held on the selected areas and pressed for approximately 20 seconds. DNA was isolated from the strip and two polymerase chain reactions (PCR) assays were used in the study: First PCR was targeting the kDNA1 minicircle of Leishmania species and the second was for species identification (L. tropica and L. major).

The tape stripping technique used was child-friendly, causes virtually no pain, and is very practical for those lesions, which occur in sensitive areas such as the eyelids, lips and ears. Of the 119 confirmed CL patients enrolled in this study, 79 patients (66%) presented with acute CL (duration ranged from one up to 12 months), 32 (27%) with chronic CL (duration ranged from 30 up to 360 months). In total, 71 patients were infected with L. tropica (60%), 41 with L. major (34%) and seven were undetermined (6%). The highest diagnostic sensitivity of 100% was achieved with the tape strip disc technique. Of 31 suspected patients, only 16 were positive for culturing parasite from lesion biopsies (sensitivity 51%), which was significantly lower than tape strip disc sampling.

The authors concluded that the duration of sampling is short (less than one minute) and species identification by PCR is highly specific and sensitive. The sequential tape stripping sampling method is a sensitive, non-invasive and cost-effective alternative to traditional diagnostic assays and it is suitable for field studies as well as for use in health care centers. The study was published on July 13, 2017, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:
Pasteur Institute of Iran
Imperial College London


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
New
Automated Immunoassay Analyzer
SuperFlex™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Molecular Diagnostics

view channel
Image: Graphical Abstract (Image Credit: Cheng N, Ouellette TW, Skead K, et al. Pre-diagnosis plasma cell-free DNA reveals early signatures of prostate and breast cancer risk up to eight years prior to clinical detection. Cell Genomics (2026). DOI:10.1016/j.xgen.2026.101364)

Blood Test Stratifies Prostate and Breast Cancer Risk Years Before Diagnosis

Cancer is the second leading cause of death globally, and late diagnosis contributes substantially to mortality. Routine screening is available for only a few cancer types, while other early detection... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Collaboration combines cognitive assessment, blood testing, phlebotomy, and MRI to support faster diagnosis across the UK (Image Credt: Adobe Stock)

New UK Collaboration Expands Access to Integrated Alzheimer’s Diagnostic Testing

C2N Diagnostics and Cambridge Cognition have partnered with The Alzheimer’s Trust to create an integrated pathway aimed at supporting earlier and more accurate diagnosis of Alzheimer’s disease and related dementias.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.